NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
A new inhaled therapy targeting lung inflammation shows promise in reducing damage and improving recovery after severe ...
A new inhaled therapy targets ANGPTL4 to reduce lung inflammation, fluid buildup, and scarring after infections. Preclinical ...
The customizable platform used AAVs to deliver genetic cargo that induced the production of three anti-inflammatory cytokines ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China’s Southern University of Science and ...
KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...
Damien Chua, PhD student; Liu Yu Xuan, Research Associate; Joseph Kim, PhD student; Cheng Hong Sheng, Senior Research Fellow; and ...
The best ways to get rid of phlegm, from using nasal sprays to taking the right OTC medications. Plus, they explain what ...
The FDA has granted Fast Track designation to KT-621, a first-in-class oral STAT6 degrader for moderate to severe ...
A Chiang Mai doctor said PM2.5 and toxic smoke were linked to serious lung cases, including a young tourist who required oxygen treatment.
COVID-19 (coronavirus) survivors may face a higher risk of lung cancer through TYMP-driven biological mechanisms.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results